GET DAILY SIGNALSMarchex (MCHX) Q3 Earnings Preview: Archenia Integration in Focus
Key Takeaways
- Marchex (MCHX) is scheduled to report results for the third quarter ended September 30, 2026, after the market close on Tuesday, November 10, 2026.
- Wall Street consensus calls for earnings per share (EPS) of about $0.04 and revenue near $16.2 million, reflecting the first full quarter of the acquired Archenia business.
- Management has guided third-quarter revenue to $16.0–$16.5 million and adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) to $2.3–$2.5 million.
- Investors will watch whether the Archenia integration delivers the promised step-change in scale, margins, and customer expansion after the deal closed on July 1, 2026.
- Marchex has said it will provide its fourth-quarter and initial 2027 outlook alongside these results, making forward guidance a central focus.
Earnings Context and Why It Matters
Marchex, a Seattle-based provider of AI-driven conversational analytics and customer acquisition tools, stands at an important juncture. The company closed its acquisition of Archenia on July 1, 2026, combining its conversation intelligence platform with a performance-based customer qualification business. This report marks the first full quarter that includes Archenia’s results, offering the clearest view yet on whether the deal can expand revenue and improve profitability. In recent quarters, revenue had declined modestly as clients migrated off legacy platforms, so the projected roughly 40% year-over-year revenue jump represents a key test for investors following the company’s turnaround.
Earnings Expectations
Analysts expect Marchex to report revenue of approximately $16.2 million for the third quarter, up sharply from $11.5 million in the same period a year earlier. Consensus EPS stands near $0.04. These figures align closely with company guidance, which calls for third-quarter revenue of $16.0–$16.5 million and adjusted EBITDA of $2.3–$2.5 million. The midpoint of that range implies sequential revenue growth of roughly 45–50% versus the second quarter, driven almost entirely by the addition of Archenia. For context, Marchex reported second-quarter revenue of $11.0 million, which came in modestly below the $11.2 million consensus, while non-GAAP EPS was $0.00 against an estimate of $0.02. Beyond the headline numbers, I’m watching adjusted EBITDA margins, customer retention among the top 100 clients, and any signs of cross-selling progress.
From what I see, one quick check with Tickeron’s AI Screener helped place these numbers in broader industry context.
Market Reaction and Investor Sentiment
Sentiment heading into this report is cautiously optimistic yet mindful of execution risk. Marchex shares have traded in a volatile range, and the stock’s reaction will likely depend on whether reported revenue and adjusted EBITDA land within or above guidance, along with the quality of forward commentary. Because this quarter represents the first full integration period for Archenia, any indication of slower-than-expected revenue conversion, margin pressure, or integration friction could weigh on the stock. Conversely, confirmation of the projected step-up in scale, combined with constructive fourth-quarter and 2027 guidance, would likely be viewed positively. Historically, Marchex has posted mixed results relative to consensus, so the guidance update may prove at least as important as the headline figures.
Forward Outlook and Key Factors to Monitor
The most important element of this report is likely to be what management says about the path forward. Marchex has indicated it will share its fourth-quarter and initial 2027 outlook on the earnings call, giving investors their first formal glimpse of post-acquisition expectations.
Investors should monitor progress toward the stated ambition of a “Rule of 30–40” financial profile, which combines annual revenue growth with adjusted EBITDA margin. This metric signals whether the combined business can scale profitably rather than simply adding top-line revenue.
Key factors to watch next include the pace of Archenia integration, retention and expansion of the top 100 customers that generate the bulk of revenue, and any movement in adjusted EBITDA margins. Cost discipline, cross-selling across the combined platform, and the company’s cash position—which may require additional equity or debt financing to support its acquisition strategy—also remain important. Broader demand for AI-driven marketing and customer acquisition tools across the auto, home services, and healthcare verticals will continue to shape the company’s growth trajectory.
I also checked this using Tickeron’s AI Trend Prediction Engine to see how the stock compares to others in the industry.
Exploring AI Tools for Earnings Analysis
In preparing for reports like this one, I often turn to Tickeron’s AI Screener to filter for comparable names and emerging technical setups. It helps surface trade ideas and market opportunities more efficiently than manual screening, which is especially useful when tracking earnings-driven moves and integration stories. The tool lets users scan thousands of stocks and ETFs with customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. For investors following names like Marchex, it can add another layer of context to the numbers.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MCHX in upward trend: 10-day moving average moved above 50-day moving average on November 06, 2026
The 10-day moving average for MCHX crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 64 cases where MCHX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
MCHX moved above its 50-day moving average on November 10, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +8.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where MCHX advanced for three days, in 161 of 221 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
Bearish Trend Analysis
The 10-day RSI Indicator for MCHX moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In 22 of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MCHX as a result. In 81 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MCHX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
MCHX broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MCHX entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.016) is normal, around the industry mean (-1.802). P/E Ratio (-10.154) is within average values for comparable stocks, (21.593). Projected Growth (PEG Ratio) (0.780) is also within normal values, averaging (1.501). MCHX's Dividend Yield (1.515) is considerably higher than the industry average of (0.084). P/S Ratio (1.439) is also within normal values, averaging (1.860).
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. MCHX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MCHX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of advertising and marketing services
Industry AdvertisingMarketingServices
Advertisement